S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.08%) $0.927
USD/NOK
(0.25%) $10.87
USD/GBP
(0.07%) $0.793
USD/RUB
(-1.05%) $91.60

Realtime updates for Calliditas Therapeutics [CALTX.ST]

Exchange: STO Sector: Healthcare Industry: Biotechnology
Last Updated28 Mar 2024 @ 07:59

-1.22% SEK 113.40

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 07:59):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases...

Stats
Today's Volume 52 476.00
Average Volume 245 585
Market Cap 6.09B
EPS SEK0 ( 2024-02-20 )
Next earnings date ( SEK-0.900 ) 2024-05-06
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -13.05
ATR14 SEK0.133 (0.12%)

Volume Correlation

Long: 0.09 (neutral)
Short: 0.65 (weak)
Signal:(35.082) Neutral

Calliditas Therapeutics Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Calliditas Therapeutics Correlation - Currency/Commodity

The country flag 0.22
( neutral )
The country flag 0.25
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.45
( neutral )
The country flag 0.66
( moderate )

Calliditas Therapeutics Financials

Annual 2023
Revenue: SEK1.21B
Gross Profit: SEK1.15B (94.99 %)
EPS: SEK-8.69
Q4 2023
Revenue: SEK451.56M
Gross Profit: SEK429.26M (95.06 %)
EPS: SEK-0.340
Q3 2023
Revenue: SEK294.59M
Gross Profit: SEK279.67M (94.94 %)
EPS: SEK-3.14
Q2 2023
Revenue: SEK269.38M
Gross Profit: SEK255.17M (94.72 %)
EPS: SEK-1.710

Financial Reports:

No articles found.

Calliditas Therapeutics

Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment of the autoimmune renal disease immunoglobulin A nephropathy. The company's lead product candidate is Setanaxib, a NOX inhibitor that is in Phase 2b/3 clinical trial for the treatment of primary biliary cholangitis; and in Phase 2 clinical trial for the treatment of squamous cell carcinoma of the head and neck cancer and idiopathic pulmonary fibrosis, as well as for type 1 diabetic kidney disease. It also develops Budenofalk 3 mg oral capsules for the treatment of autoimmune hepatitis. The company was incorporated in 2004 and is headquartered in Stockholm, Sweden.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators